NEW YORK--(BUSINESS WIRE)--Lescarden Inc. (LCAR.OB), a marketing and R&D company based in New York, today announced that it has received its first order for Poly-NAG® from Pascual Laboratories Inc., one of the largest privately owned pharmaceutical companies in the Philippines. This order follows the marketing approval of Poly-NAG® by the Filipino Bureau of Food and Drug (BFAD). Under the terms of the agreement announced in December 2005, Pascual Laboratories has exclusive rights to the marketing and selling of Lescarden’s patented product Poly-NAG®, a clinically proven, slow-release glucosamine for the treatment of osteoarthritis.
